Diagnostic usefulness of PCR profiling of the differentially expressed marker genes in thyroid papillary carcinomas

被引:15
作者
Hamada, A
Mankovskaya, S
Saenko, V
Rogounovitch, T
Mine, M
Namba, H
Nakashima, M
Demidchik, Y
Demidchik, E
Yamashita, S
机构
[1] Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Dis Ins, Dept Int Hlth & Radiat Res, Nagasaki 8528523, Japan
[2] Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Dis Ins, Dept Mol Med, Nagasaki 8528523, Japan
[3] Nagasaki Univ, Grad Sch Biomed Sci, Dept Biomed Stat, Atom Bomb Dis Inst, Nagasaki 8528523, Japan
[4] Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Dis Ins, Tissue & Histopathol Sect, Nagasaki 8528523, Japan
[5] Belarussian State Med Univ, Minsk 220116, BELARUS
关键词
papillary thyroid carcinoma; preoperative diagnosis; fine needle aspiration biopsy; laboratory test;
D O I
10.1016/j.canlet.2004.10.012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The study was set out to determine whether characteristic changes in the gene expression profile in papillary thyroid carcinoma (PTC) discovered by microarray assays can be used for conventional molecular diagnosis. Expression levels of five reported to be overexpressed and three underexpressed genes were examined in PTC and normal human tissues by real-time PCR and semi-quantitative duplex PCR. Stepwise logistic regression analysis, duplex PCR data evaluation with recursive partition machine algorithm and hierarchical cluster analysis identified SFTPB (upregulated) and TFF3 (downregulated) gene combination as most favorable for differential molecular diagnosis of PTC. Sensitivity, specificity and accuracy obtained in a series of histologically characterized thyroid tumor and normal tissue samples were 88.9, 96.7 and 94.9%, respectively. Applicability of the method to fine needle aspiration biopsy (FNAB) samples was demonstrated using a collection of needle washouts. In spite individual thyroid tumor and normal tissues as well as FNAB samples displayed a substantial degree of variability in the expression levels of analyzed genes, simultaneous molecular analysis of a panel of optimal markers allows making a high probability predictive estimate and may be considered as an informative method of preoperative PTC diagnosis. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:289 / 301
页数:13
相关论文
共 35 条
[31]   Molecular pathobiology of thyroid neoplasms [J].
Tallini, G .
ENDOCRINE PATHOLOGY, 2002, 13 (04) :271-288
[32]   Genome-wide profiling of papillary thyroid cancer identifies MUC1 as an independent prognostic marker [J].
Wreesmann, VB ;
Sieczka, EM ;
Socci, ND ;
Hezel, M ;
Belbin, TJ ;
Childs, G ;
Patel, SG ;
Patel, KN ;
Tallini, G ;
Prystowsky, M ;
Shaha, AR ;
Kraus, D ;
Shah, JP ;
Rao, PH ;
Ghossein, R ;
Singh, B .
CANCER RESEARCH, 2004, 64 (11) :3780-3789
[33]   Detection of BRAF mutation on fine needle aspiration biopsy specimens:: A new diagnostic tool for papillary thyroid cancer [J].
Xing, MZ ;
Tufano, RP ;
Tufaro, AP ;
Basaria, S ;
Ewertz, M ;
Rosenbaum, E ;
Byrne, PJ ;
Wang, J ;
Sidransky, D ;
Ladenson, PW .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) :2867-2872
[34]  
Yamachika T, 2002, CLIN CANCER RES, V8, P1092
[35]   Gene expression profiling identifies platelet-derived growth factor as a diagnostic molecular marker for papillary thyroid carcinoma [J].
Yano, Y ;
Uematsu, N ;
Yashiro, T ;
Hara, H ;
Ueno, E ;
Miwa, M ;
Tsujimoto, G ;
Aiyoshi, Y ;
Uchida, K .
CLINICAL CANCER RESEARCH, 2004, 10 (06) :2035-2043